**Question:** Which one of the following local anesthetics is highly cardio-toxic:

A. Bupivacaine
B. Lidocaine
C. Prilocaine
D. Ropivacaine

**Core Concept:** Local anesthetics are a class of medications commonly used for regional anesthesia and pain management. They work by blocking voltage-gated sodium channels in neurons, preventing the transmission of pain signals. Cardiotoxicity refers to the potential for local anesthetics to cause cardiac dysfunction or arrhythmias.

**Why the Correct Answer is Right:** Bupivacaine is a potent local anesthetic with a long duration of action. It has a higher potency and a longer half-life compared to other local anesthetics, which increases the risk of toxicity. High plasma concentrations can lead to cardiotoxicity due to blockade of sodium channels in the heart, causing cardiac depression and arrhythmias.

**Why Each Wrong Option is Incorrect:**

B. Lidocaine: Although lidocaine is also a potent local anesthetic, it has a shorter half-life and lower potency, reducing the risk of toxicity.

C. Prilocaine: Prilocaine is a local anesthetic with a similar potency to lidocaine and a shorter half-life, decreasing the likelihood of toxicity.

D. Ropivacaine: Ropivacaine is also a potent local anesthetic with a similar potency to lidocaine and a shorter half-life, further reducing the risk of toxicity compared to bupivacaine.

**Clinical Pearl:** When using local anesthetics for regional anesthesia, consider the potency, half-life, and clinical context to minimize the risk of toxicity. Choose lower potency agents with shorter half-lives, such as lidocaine or ropivacaine, over bupivacaine or prilocaine. In high-risk situations (e.g., in patients with pre-existing cardiac conditions), opt for local anesthetics with lower potency and shorter half-life to reduce the risk of cardiotoxicity.